Showing results (461-470 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant TherapyPat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
JCO Precision Oncology|September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant TherapiesVladimir Lazar, Nicolas Girard, Eric Raymond, et al.
JCO Precision Oncology|September 14, 2022
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical TrialRachel W Miller, Megan L Hutchcraft, Heidi L Weiss, et al.
JCO Precision Oncology|October 6, 2022
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World OutcomesJulie Wu, Victoria Ding, Sophia Luo, et al.
JCO Precision Oncology|August 31, 2022
Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and FunctionAfshin Dowlati, Ata Abbas, Timothy Chan, et al.
JCO Precision Oncology|February 24, 2022
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast CancerGabriella Cirmena, Lorenzo Ferrando, Francesco Ravera, et al.
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
JCO Precision Oncology|February 16, 2022
Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer TypesYan Yin, Lijie Song, Dongsheng Shi, et al.
JCO Precision Oncology|February 17, 2022
Persistent Severe Hyperlactatemia and Metabolic Derangement in Lethal SDHB-Mutated Metastatic Kidney Cancer: Clinical Challenges and Examples of Extreme Warburg EffectChung-Han Lee, Gunes Gundem, William Lee, et al.
JCO Precision Oncology|February 17, 2022
Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-AnalysisDoah Cho, Felicia T Roncolato, Johnathan Man, et al.
Pageof 140